This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Nathalie Chatzissavidou: Innovator in Recombinant Protein Expression
Introduction
Nathalie Chatzissavidou is a prominent inventor based in Södertälje, Sweden. She has made significant contributions to the field of biotechnology, particularly in the area of recombinant protein expression. Her innovative work has led to the development of a unique patent that showcases her expertise and dedication to advancing scientific knowledge.
Latest Patents
Nathalie holds a patent titled "Novel Combination of TIS Sequence and Signal Peptide Sequence for Expressing a Recombinant Protein." This patent represents her innovative approach to enhancing the efficiency of protein expression, which is crucial for various applications in medicine and research. She has 1 patent to her name, reflecting her commitment to innovation in her field.
Career Highlights
Nathalie is currently employed at Intas Pharmaceuticals Limited, where she continues to work on groundbreaking projects in biotechnology. Her role at the company allows her to collaborate with other talented professionals and contribute to the development of new therapeutic solutions. Her career is marked by a strong focus on research and development, driving advancements in the pharmaceutical industry.
Collaborations
Throughout her career, Nathalie has worked alongside notable colleagues, including Siavash Bashiri and Veronica Ramberg. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of various projects in the field of biotechnology.
Conclusion
Nathalie Chatzissavidou is a remarkable inventor whose work in recombinant protein expression has made a significant impact in biotechnology. Her patent and contributions to Intas Pharmaceuticals Limited highlight her dedication to advancing scientific research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile